for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zhejiang Medicine Co., Ltd.

600216.SS

Latest Trade

11.88CNY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

7.81

 - 

14.03

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
11.88
Open
--
Volume
--
3M AVG Volume
380.56
Today's High
--
Today's Low
--
52 Week High
14.03
52 Week Low
7.81
Shares Out (MIL)
965.26
Market Cap (MIL)
11,467.26
Forward P/E
19.16
Dividend (Yield %)
1.26

Next Event

Q3 2019 Zhejiang Medicine Co Ltd Earnings Release

Latest Developments

More

Zhejiang Medicine's Net Profit Down In Q1, Up In 2018 From Year Earlier

Zhejiang Medicine Plans Share Buyback Worth 50-150 Million Yuan Within Six Months

Zhejiang Medicine Says 9-Month Net Profit Up 291.4 Percent Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Zhejiang Medicine Co., Ltd.

Zhejiang Medicine Co., Ltd. is a China-based company, principally engaged in the manufacture and distribution of drugs and nourishments. The Company mainly provides nourishments for animals and human, health care products, and chemicals and chemical raw materials, among others. The Company's products include synthetic vitamin E, natural vitamin E soft capsules, Beta carotene, vancomycin hydrochloride for injection and teicoplanin for injection, among others. The Company distributes its products within domestic market and to overseas markets.

Industry

Major Drugs

Contact Info

No. 58 Changhe Road, Binhai New City

+86.575.85211969

http://www.china-zmc.com

Executive Leadership

Chunbo Li

Chairman of the Board

Dingkuan Chen

Deputy General Manager

Yong Hui Lu

Deputy General Manager

Wenxin Ma

Deputy General Manager

Dingfeng Zhang

Deputy General Manager

Key Stats

1.00 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2017

5.7K

2018

6.9K

2019(E)

7.4K
EPS (CNY)

2017

0.270

2018

0.380

2019(E)

0.620
Price To Earnings (TTM)
61.60
Price To Sales (TTM)
1.63
Price To Book (MRQ)
1.48
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
10.76
LT Debt To Equity (MRQ)
0.77
Return on Investment (TTM)
1.73
Return on Equity (TTM)
1.32

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up